Numinus Wellness Inc.
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Numinus Wellness Inc. is a mental health care company specializing in the development and delivery of innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies. It operates through multiple segments including clinical research operations, practitioner training, and a network of clinics providing mental health services. The company offers a range of services and products including psychedelic-assisted therapy training; clinical trial research management; laboratory services encompassing cultivation, production, and extraction of psychoactive fungi such as Psilocybe; traditional psychotherapy; ketamine-assisted therapies; mindfulness programs; virtual psychotherapy; neurological care; transcranial magnetic stimulation; and psychiatric and medical model management services across Canada and the United States. Founded in 1964 and headquartered in Vancouver, British Columbia, Numinus serves a diverse client base targeting mental health conditions including depression, anxiety, trauma, pain, and substance use disorder. The company’s research and training programs support the integration of psychedelic-assisted therapies into mainstream clinical practice, fostering a comprehensive ecosystem of mental health solutions. Recent major company changes include the November 2024 sale of its five U.S. wellness clinics to Stella, an interventional psychiatry practice, for $3.53 million, enabling Numinus to shift focus towards technology-driven solutions to enhance clinic efficiency and care reimbursement. Concurrently, Numinus established a strategic partnership with Stella to leverage operational data from Stella’s network of 12 mental health clinics to develop advanced clinic management SaaS solutions. In June 2024, Numinus announced plans to acquire MedBright AI Investments Inc., aiming to integrate AI-enabled clinical solutions with its expertise in drug-assisted therapy to improve clinical operations and facilitate reimbursable offerings. This acquisition is accompanied by a planned rebranding to "Numinus Intelligence" to reflect the company’s strategic focus on leveraging AI and data science to expand mental health services across the U.S. Through clinical research, practitioner training, and the development of technology-driven mental health solutions, Numinus Wellness Inc. continues to build on its mission to transform mental health care by integrating psychedelic-assisted therapies into mainstream clinical use and supporting practitioners with innovative tools and research capabilities. This comprehensive approach positions Numinus at the forefront of a transformative shift from symptom management to healing in mental health treatment. The company’s operational and strategic shifts underscore its evolving role as a leader in psychedelic-assisted therapy and mental health innovation in North America. All information is up to date as of late 2025.
Numinus Wellness Responds to Trump Executive Order on Psychedelic Therapies
Numinus Wellness Provides Update Regarding Listing Status
Numinus Wellness Provides Corporate Update
Numinus Wellness Advises of a Change of Auditor
Numinus Wellness Inc. (OTCMKTS:NUMIF) Short Interest Update
Numinus Wellness Provides Corporate Update
Numinus Wellness Announces Change of Auditor
Numinus Wellness Inc. Announces Third Quarter Fiscal 2025 Results
Numinus Wellness Inc. Announces Second Quarter Fiscal 2025 Results
Numinus Wellness Inc. Announces First Quarter Fiscal 2025 Results
Numinus Wellness Inc. Announces Fourth Quarter Fiscal 2024 Results
Numinus Approved as a State-Certified Natural Medicine Training Program in Colorado
Numinus Wellness Inc. Announces CFO Transition
Numinus Wellness Inc. Announces Strategic Wind-Down of Non-Operating Subsidiaries
Numinus Wellness Announces Corporate Update
Numinus Provides Bi-Weekly Update on Annual Filings
Numinus Provides Bi-Weekly Update on Annual Filings
Numinus Wellness Closes Sale of Clinics and Launches Initiative to Increase Access to Mental Health Care
Numinus Provides Bi-Weekly Update on Annual Filings
Numinus Applies for Management Cease Trade Order